UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 41 filers reported holding UROGEN PHARMA LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $94,000 | +9.3% | 4,829 | +1.5% | 0.00% | – |
| Q4 2020 | $86,000 | -61.3% | 4,758 | -58.7% | 0.00% | – |
| Q3 2020 | $222,000 | -24.5% | 11,512 | +2.1% | 0.00% | -100.0% |
| Q2 2020 | $294,000 | +182.7% | 11,274 | +93.9% | 0.00% | 0.0% |
| Q1 2020 | $104,000 | -44.4% | 5,814 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $187,000 | +34.5% | 5,616 | -3.7% | 0.00% | 0.0% |
| Q3 2019 | $139,000 | -33.5% | 5,832 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $209,000 | +26.7% | 5,813 | +30.1% | 0.00% | 0.0% |
| Q1 2019 | $165,000 | -12.2% | 4,468 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $188,000 | +16.0% | 4,364 | +27.6% | 0.00% | 0.0% |
| Q3 2018 | $162,000 | +1.2% | 3,420 | +6.1% | 0.00% | 0.0% |
| Q2 2018 | $160,000 | +6.7% | 3,224 | +6.5% | 0.00% | 0.0% |
| Q1 2018 | $150,000 | +42.9% | 3,026 | +7.2% | 0.00% | 0.0% |
| Q4 2017 | $105,000 | – | 2,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |